If ARKG continues to run as expected into JPM season...
I think it's completely reasonable for $NAUT, $PDSB, and $QSI to rally toward ~$10 in the near future.
Invalidated if structures break, but generally speaking, betting on biotech in Q4 usually plays out well.
Multiple buy-signals are starting to appear for $PDSB.
If you missed our $NAUT trade for nearly ~3x... probably don't miss out on this?
$ARKG (biotech ETF) starting to break out as well, high likelihood we see some aggressive rallies in these smaller caps.